During pregnancy, various immune effectors and molecules participating in the immune-
microenvironment establish specific maternal tolerance toward the semi-allogeneic fetus …

Preeclampsia (PE), a hypertensive disorder, occurs in 3% to 8% of pregnancies in the
United States and affects over 200,000 women and newborns per year. The United States …

Preeclampsia is a common pregnancy complication, affecting 2% to 8% of pregnancies
worldwide, and is an important cause of both maternal and fetal morbidity and mortality …

Pregnant women infected with pathogenic respiratory viruses, such as influenza A viruses
(IAV) and coronaviruses, are at higher risk for mortality, hospitalization, preterm birth, and …

The population of T lymphocytes producing IL‐17 (Th17) plays a dual role during pregnancy
and its activity is tightly controlled during this period. One of the factors involved in this …

Abstract Problem The Reduced Uterine Perfusion Pressure (RUPP) rat model of placental
ischemia recapitulates many characteristics of preeclampsia including maternal …

Background Antiphospholipid syndrome (APS) is a group of clinical syndromes of
thrombosis or adverse pregnancy outcomes caused by antiphospholipid antibodies, which …

Hypertensive nephropathy (HTN) is the second leading cause of end-stage renal disease
(ESRD) and a chronic inflammatory disease. Persistent hypertension leads to lesions of …

T-helper (TH) 17s, IL-17, and cytolytic natural killer cells (cNKs) are increased in
preeclampsia and contribute to the hypertension, inflammation, and fetal growth restriction …

Preeclampsia (PE) is a leading cause of maternal and fetal mortality worldwide. The immune
system plays a critical role in normal pregnancy progression; however, inappropriate …